User: Guest  Login
Title:

GOLD study: An international Phase III study of TKI258/Dovitinib versus Sorafenib in patients with metastatic renal cell cancer (mRCC) as third line therapy

Document type:
Meeting Abstract
Author(s):
Grunwald, V; Kube, U; Eichelberg, C; Zürn, C; Gschwend, J
Journal title abbreviation:
Onkologie
Year:
2012
Journal volume:
35 6
Pages contribution:
202-203
Language:
eng
Print-ISSN:
0378-584X
TUM Institution:
Urologische Klinik und Poliklinik
 BibTeX